Product NDC: | 51079-402 |
Proprietary Name: | Ciprofloxacin |
Non Proprietary Name: | ciprofloxacin |
Active Ingredient(s): | 250 mg/1 & nbsp; ciprofloxacin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-402 |
Labeler Name: | UDL Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075685 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110628 |
Package NDC: | 51079-402-20 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-402-20) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-402-01) |
NDC Code | 51079-402-20 |
Proprietary Name | Ciprofloxacin |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-402-20) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-402-01) |
Product NDC | 51079-402 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ciprofloxacin |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110628 |
Marketing Category Name | ANDA |
Labeler Name | UDL Laboratories, Inc. |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |